Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001995601-24-000007
Filing Date
2024-11-21
Accepted
2024-11-21 10:59:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G CMMB13g.htm SC 13G 29567
  Complete submission text file 0001995601-24-000007.txt   31054
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86953 | Film No.: 241482834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 641 OLIVER STREET VICTORIA A1 V8S4W2
Business Address
Otto Erik (Filed by) CIK: 0001995601 (see all company filings)

Type: SC 13G